The first-ever preventative treatment for migraine in adults, Aimovig (erenumab-aooe) is now approved by the Food and Drug Administration.

This once-monthly self-injection is the first of its kind and may have a significant impact on the likelihood and intensity of migraines in patients.

Find out more about this new medicine and how it works here.